Patent · US Active

Solid forms of ((s)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile

US11723905B2 · kind B2 · utility

0Cited by

34References

27Claims

0Family size

Assignee

FORMA Therapeutics, Inc. · US

Inventors

George P. Luke · Clinton, US
Pratik Sheth · Watertown, US

Key dates

Filing date	Feb 24, 2021
Grant date	Aug 15, 2023
Priority date	—
Expiry date	Aug 23, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure reports solid forms of ((S)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.